-
1 Comment
Aurora Cannabis Inc is currently in a long term downtrend where the price is trading 8.9% below its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.
Aurora Cannabis Inc's total revenue rose by 20.8% to $68M since the same quarter in the previous year.
Its net income has increased by 77.2% to $-293M since the same quarter in the previous year.
Finally, its free cash flow grew by 70.3% to $-78M since the same quarter in the previous year.
Based on the above factors, Aurora Cannabis Inc gets an overall score of 4/5.
ISIN | CA05156X8504 |
---|---|
Exchange | TO |
CurrencyCode | CAD |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Beta | 3.42 |
---|---|
PE Ratio | 24.78 |
Target Price | 10.75 |
Market Cap | 367M |
Dividend Yield | None |
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ACB.TO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025